(1) Trifecta of bad headlines for Tech sector. (2) Facebook is in our faces. (3) Tech M&A will continue. (4) Earnings remain bullish for Tech, and valuations are reasonably high. (5) Tech IPOs still attracting buyers. (6) Crispr 101. (7) Cutting diseases out of our DNA. (8) Is there method in Trump's March tariff madness?
End of free preview
Ed's complete analysis, every chart linked, and the archive back to 2009.
Individual investor? Ed's QuickTakes are available for personal use at yardeniquicktakes.com →